CannLabs Inc. (CANL) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
3888 E. MEXICO AVENUE DENVER, CO 80210 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8071 - Medical Laboratories (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 33 | ||||
| Cash and cash equivalents | 33 | ||||
| Receivables | |||||
| Prepaid expense | ✕ | ||||
| Total current assets: | 33 | ||||
| Noncurrent Assets | |||||
| Property, plant and equipment | 177 | 32 | |||
| Intangible assets, net (including goodwill) | ✕ | ✕ | |||
| Intangible assets, net (excluding goodwill) | |||||
| Other noncurrent assets | ✕ | ||||
| Other undisclosed noncurrent assets | |||||
| Total noncurrent assets: | 177 | 32 | |||
| TOTAL ASSETS: | 210 | 32 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities, including: | 22 | 15 | |||
| Interest and dividends payable | |||||
| Accounts payable | 22 | 15 | |||
| Other undisclosed accounts payable and accrued liabilities | |||||
| Debt | 2 | ||||
| Deferred revenue and credits | |||||
| Due to related parties | |||||
| Other undisclosed current liabilities | 83 | 13 | |||
| Total current liabilities: | 106 | 30 | |||
| Noncurrent Liabilities | |||||
| Long-term debt and lease obligation | |||||
| Long-term debt, excluding current maturities | |||||
| Capital lease obligations | |||||
| Liabilities, other than long-term debt | |||||
| Due to related parties | |||||
| Total noncurrent liabilities: | |||||
| Other undisclosed liabilities | |||||
| Total liabilities: | 106 | 30 | |||
| Equity | |||||
| Equity, attributable to parent, including: | 104 | 2 | |||
| Preferred stock | |||||
| Common stock | 17 | 17 | |||
| Additional paid in capital | 1,584 | 1,403 | |||
| Accumulated deficit | |||||
| Other undisclosed equity, attributable to parent | (1,497) | (1,417) | |||
| Equity, attributable to noncontrolling interest | |||||
| Other undisclosed equity | |||||
| Total equity: | 104 | 2 | |||
| TOTAL LIABILITIES AND EQUITY: | 210 | 32 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|
| Revenues | 84 | 146 | ||
| Revenue, net | ||||
| Financial services revenue | 16 | |||
| Cost of revenue (Cost of Goods and Services Sold) | ||||
| Gross profit: | 84 | 146 | ||
| Operating expenses | (178) | (173) | ||
| Other undisclosed operating income | 16 | |||
| Operating loss: | (78) | (26) | ||
| Nonoperating expense | (1) | |||
| Other nonoperating expense | (1) | |||
| Interest and debt expense | (1) | (1) | ||
| Loss from continuing operations before income taxes: | (80) | (28) | ||
| Income tax expense (benefit) | (5) | |||
| Loss from continuing operations: | (80) | (33) | ||
| Loss before gain (loss) on sale of properties: | (80) | (33) | ||
| Other undisclosed net loss | ||||
| Net loss: | (80) | (33) | ||
| Net income attributable to noncontrolling interest | ||||
| Other undisclosed net income (loss) attributable to parent | 1 | 5 | ||
| Net loss attributable to parent: | (79) | (28) | ||
| Preferred stock dividends and other adjustments | ||||
| Net loss available to common stockholders, diluted: | (79) | (28) | ||
Comprehensive Income ($ in thousands)
| 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|
| Net loss: | (80) | (33) | ||
| Comprehensive loss: | (80) | (33) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | ||||
| Comprehensive loss, net of tax, attributable to parent: | (80) | (33) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.